Gudrun E. Koehl

7.3k citations

44 papers · 4.0k indexed · 1 hit paper · h-index 28

Impact in

Transplantation top 1%
- Renal Transplantation Outcomes and Treatments
Oncology top 2%
- Polyomavirus and related diseases
- Viral-associated cancers and disorders

Papers in

Transplantation 2
Immunology 14
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 6

Co-authors: Edward K. Geissler Markus Steinbauer Markus Guba Karl‐Walter Jauch Christiane J. Bruns Matthias Anthuber Stefan Farkas Hans J. Schlitt
Journals: Transplantation (8 papers)The Journal of Immunology (6 papers)Clinical Cancer Research (3 papers)International Journal of Cancer (3 papers)Cancer Prevention Research (1 paper)
Partner nations: Germany United States Netherlands

In The Last Decade

Gudrun E. Koehl

44 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor 2002 · 1.4k citations

Peers

Countries citing papers authored by Gudrun E. Koehl

Since Specialization

Citations

This map shows the geographic impact of Gudrun E. Koehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudrun E. Koehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudrun E. Koehl more than expected).

Fields of papers citing papers by Gudrun E. Koehl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gudrun E. Koehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudrun E. Koehl. The network helps show where Gudrun E. Koehl may publish in the future.

Co-authors

The 25 scholars most cited alongside Gudrun E. Koehl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gudrun E. Koehl Line = papers co-authored together Gudrun E. Koehl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment Frontiers in Immunology ·Kathrin Renner, Katrin Singer, Gudrun E. Koehl, Edward K. Geissler, Katrin Peter, Peter J. Siska, Marina Kreutz	2017	286
2	Cyclosporine A Inhibits the T-bet–Dependent Antitumor Response of CD8+ T Cells American Journal of Transplantation ·Jordi Rovira, Philipp Renner, M. Ignatiev, Elke Eggenhofer, Gudrun E. Koehl, Margaréta Lantow, Sven Arke Lang, Hans J. Schlitt, Josep M. Campistol, Edward K. Geissler, Alexander Kroemer	2016	14
3	RORγt+ IL-22-producing NKp46+ cells protect from hepatic ischemia reperfusion injury in mice Journal of Hepatology ·Elke Eggenhofer, Nicolae Teclu, Margaréta Lantow, Philipp Renner, Jordi Rovira, Gudrun E. Koehl, Hans J. Schlitt, Edward K. Geissler, Alexander Kroemer	2015	20
4	D-dimers Are a Predictor of Clot Volume Inside Membrane Oxygenators During Extracorporeal Membrane Oxygenation Artificial Organs ·Christian Dornia, Alois Philipp, 김세서리아, Christian Stroszczynski, A. Schreyer, Thomas Müller, Gudrun E. Koehl, Karla Lehle	2015	53
5	No Acceleration of UV-Induced Skin Carcinogenesis from Evenly Spread Dietary Intake of Cyclosporine in Contrast to Oral Bolus Dosages Transplantation ·E.М. Игнатович, Reid Julian, Gudrun E. Koehl, Cornelis P. Tensen, Jan Nico Bouwes Bavinck, Rein Willemze, Edward K. Geissler, Frank R. de Gruijl	2013	4
6	Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas Cancer Prevention Research ·E.М. Игнатович, Reid Julian, Gudrun E. Koehl, Heggert Rebel, J.F. de Kort, Andreas Gäumann, K. G. Predko, Cornelis P. Tensen, Jan Nico Bouwes Bavinck, Rein Willemze, Edward K. Geissler, Frank R. de Gruijl	2012	8
7	Dose-Dependent Effects of Sirolimus on mTOR Signaling and Polycystic Kidney Disease Journal of the American Society of Nephrology ·Zlata Novalić, Carlos Andrés Peña Torres, Wouter N. Leonhard, Gudrun E. Koehl, Martijn H. Breuning, Edward K. Geissler, Emile de Heer, Dorien J.M. Peters	2012	83
8	A Color-Coded Reporter Model to Study the Effect of Immunosuppressants on CD8+ T-Cell Memory in Antitumor and Alloimmune Responses Transplantation ·Jordi Rovira, M. Ignatiev, Elke Eggenhofer, Margaréta Lantow, Gudrun E. Koehl, Hans J. Schlitt, Josep M. Campistol, Edward K. Geissler, Alexander Kroemer	2012	14
9	Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cells Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Sven A. Lang, Christina Hackl, Christian Moser, Stefan Fichtner‐Feigl, Gudrun E. Koehl, Hans J. Schlitt, Edward K. Geissler, Oliver Stoeltzing	2010	42
10	Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APCMin/+ mice Oncogene ·Gudrun E. Koehl, Melanie Spitzner, Jiraporn Ousingsawat, Rainer Schreiber, Edward K. Geissler, Karl Kunzelmann	2009	50
11	Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies Clinical & Experimental Metastasis ·Gudrun E. Koehl, Andreas Gäumann, Edward K. Geissler	2009	45
12	Early and late effects of the immunosuppressants rapamycin and mycophenolate mofetil on UV carcinogenesis International Journal of Cancer ·Frank R. de Gruijl, Gudrun E. Koehl, E.М. Игнатович, Anne S. Strik, Heggert Rebel, Andreas Gäumann, Johan W. de Fijter, Cornelis P. Tensen, Jan Nico Bouwes Bavinck, Edward K. Geissler	2009	36
13	Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model Histochemistry and Cell Biology ·Stephanie Alexander, Gudrun E. Koehl, M.E. Hirschberg, Edward K. Geissler, Peter Friedl	2008	210
14	Defibrotide: An endothelium protecting and stabilizing drug, has an anti-angiogenic potential in vitro and in vivo Cancer Biology & Therapy ·Gudrun E. Koehl, Edward K. Geissler, Massimo Iacobelli, Istvan Knijff, Cuadrado Idoyaga F, Silvia Haffner, Ernst Holler, Reinhard Andreesen, Hans J. Schlitt, Günther Eißner	2007	29
15	Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model International Journal of Cancer ·Sven A. Lang, Andreas Gäumann, Gudrun E. Koehl, Ulrike Seidel, Frauke Bataille, Dagmar Klein, Lee M. Ellis, Ulrich Bolder, Ferdinand Hofstaedter, Hans J. Schlitt, Edward K. Geissler, Oliver Stoeltzing	2007	138
16	Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant Model Transplantation ·Seiichiro Inoue, Felix Popp, Gudrun E. Koehl, Pompiliu Piso, Hans J. Schlitt, Edward K. Geissler, Marc H. Dahlke	2006	212
17	Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer Transplant International ·Markus Guba, Gudrun E. Koehl, Saniye Tuğba Tokel, Axel Doenecke, Markus Steinbauer, Hans J. Schlitt, Karl‐Walter Jauch, Edward K. Geissler	2004	79
18	Blockage of 2-Deoxy-d-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy Clinical Cancer Research ·Hendrik Seeliger, Markus Guba, Gudrun E. Koehl, Axel Doenecke, Markus Steinbauer, Christiane J. Bruns, Christine Wagner, Miriam E. David, Karl‐Walter Jauch, Edward K. Geissler	2004	54
19	Rapamycin treatment at immunosuppressive doses affects tumor blood vessel circulation Transplantation Proceedings ·Gudrun E. Koehl, Markus Guba, Hendrik Seeliger, Markus Steinbauer, Matthias Anthuber, K.‐W. Jauch, Edward K. Geissler	2003	9
20	A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. PubMed ·Tomáš Hoch, Grigore Cernaianu, Gudrun E. Koehl, Edward K. Geissler, 隆安岡, Matthias Anthuber, Werner Falk, Markus Steinbauer	2001	107

About Gudrun E. Koehl

Gudrun E. Koehl is a scholar working on Transplantation, Immunology, Cancer Research, Immunology and Allergy and Oncology, having authored 44 papers that have together received 4.0k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (11 papers), Angiogenesis and VEGF in Cancer (10 papers), Immune Cell Function and Interaction (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), T-cell and B-cell Immunology (6 papers), Cancer Research and Treatments (4 papers), Polyomavirus and related diseases (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Transplantation (352 citations), Oncology (1.2k citations), Cancer Research (615 citations), Genetics (334 citations) and Immunology (599 citations). Gudrun E. Koehl has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Edward K. Geissler, Markus Steinbauer, Markus Guba, Karl‐Walter Jauch, Christiane J. Bruns, Matthias Anthuber, Stefan Farkas, Hans J. Schlitt, Carl Zuelke and Philipp von Breitenbuch. Their work appears in journals such as Transplantation, The Journal of Immunology, Clinical Cancer Research, International Journal of Cancer and Cancer Prevention Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact